Search for: "IPR Pharmaceuticals, Inc."
Results 21 - 40
of 182
Sorted by Relevance
|
Sort by Date
24 Mar 2014, 9:13 pm
The cases were IPR2012-00006, IPR2012-00007, and IPR2013-00011, and the parties were Illumina, Inc. [read post]
21 Dec 2016, 7:18 am
Mylan Pharmaceutical Inc. says they expect PTAB decisions on the IPRs sometime during the fourth quarter of 2017. [read post]
18 Jun 2019, 11:31 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
25 Aug 2018, 9:09 pm
Teva Pharmaceuticals decision holding that the defense of tribal sovereign immunity does not apply to IPR proceedings; • Assessing the latest decisions on § 101 and their implications for branded pharmaceuticals; • Reviewing the state... [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d... [read post]
15 Apr 2019, 7:19 pm
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
13 Dec 2023, 1:08 pm
In United Therapeutics Corp. v Liquidia Tech Inc., the Federal Circuit reviewed the district court’s decision on invalidity and infringement of two pharmaceutical patents and the impact of the Final Written Decision (FWD) in a parallel inter-partes review (IPR) upon the district court’s decision. [read post]
22 Jul 2014, 9:59 pm
These cases, which were issued on June 20, 2014, were IPR2013-00116, IPR2013-00117, IPR2013-00118, and IPR2013-00119, and the parties were Gnosis S.P.A., Gnosis Bioresearch S.A., and Gnosis U.S.A., Inc. [read post]
6 Feb 2019, 5:15 pm
Statutory Right to Appeal for Joined Parties In Mylan Pharmaceuticals Inc. v. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
26 Jan 2016, 11:23 am
The pharma industry is right to worry about IPRs. [read post]
24 Apr 2020, 5:24 am
,Sun Pharmaceutical Industries, Inc., and Sun PharmaGlobal FZE’s (collectively, Sun); Teva PharmaceuticalsUSA, Inc. and Actavis Elizabeth LLC’s; and ArgentumPharmaceuticals LLC’s requests for joinder under 35U.S.C. [read post]
22 May 2017, 9:22 am
Noven Pharmaceuticals, Inc., which affirmed the Patent Trial and Appeal Board (PTAB) invalidation of claims in related inter partes review (IPR) proceedings. [read post]
28 Mar 2018, 6:56 pm
Mylan Pharmaceuticals Inc. [read post]
25 May 2023, 6:00 am
Mylan Pharmaceuticals Inc., No. 2021-1981, 2023 U.S. [read post]
5 Sep 2015, 11:58 am
A different three-judge panel on Sept. 1 said information of a clinical trial wasn’t evidence that could be used to challenge Biogen Inc. [read post]
25 Aug 2023, 1:29 am
Resideo Technologies, Inc., August 8, 2023, Newman, P.). [read post]
4 Feb 2019, 8:59 am
Inc. v. [read post]
25 Jul 2018, 12:47 pm
Mylan Pharmaceuticals Inc. et al., the U.S. [read post]
